Article
An accurate cellular assay to determine pathogenicity of coding and noncoding variants in Lynch syndrome genes.
Proceedings of the National Academy of Sciences of the United States of America - 20 Jan 2026
Glykofridis Iris E, Dekker Marleen, Stoepker Chantal, van Ravesteyn Thomas W, Tiersma Yvonne, van der Ham Cédric G, de Bruijn Beaunelle, Ebrahim Salma, de Menezes Renée X, Kasteleijn Esmee, Verheijen Frans, van Ham Tjakko J, Te Riele Hein
Abstract excerpt
Lynch syndrome (LS) is a genetic predisposition to mainly colorectal and endometrial cancer due to heterozygous disruptive germline mutations in the DNA mismatch-repair (MMR) genes MSH2, MSH6, MLH1, or PMS2. Beyond clearly pathogenic mutations, germline sequencing often reveals variants of uncertain significance (VUS), predominantly single base-pair alterations in coding or noncoding regions. These uncertain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
